Ioannis P Trougakos Selected Research

Immunoglobulin M (IgM)

11/2022

Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ioannis P Trougakos Research Topics

Disease

46	Neoplasms (Cancer) 03/2023 - 11/2002
21	COVID-19 11/2023 - 01/2021
13	Carcinogenesis 03/2023 - 11/2002
13	Multiple Myeloma 02/2023 - 12/2017
5	Inflammation (Inflammations) 03/2024 - 01/2009
5	Breast Neoplasms (Breast Cancer) 03/2023 - 12/2021
5	Cardiotoxicity 01/2023 - 01/2019
5	Melanoma (Melanoma, Malignant) 08/2022 - 01/2016
5	Osteosarcoma (Osteogenic Sarcoma) 01/2010 - 03/2004
4	Infections 11/2023 - 01/2020
4	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2023 - 11/2021
3	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2023
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2023 - 01/2009
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 04/2018
3	Genomic Instability 10/2019 - 12/2006
2	Immunoglobulin Light-chain Amyloidosis 02/2023 - 03/2021
2	Disease Progression 01/2023 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 09/2022 - 10/2021
2	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2022 - 09/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2022 - 09/2021
2	Amyloidosis 01/2022 - 01/2022
2	Residual Neoplasm 03/2021 - 12/2019
2	Premature Aging 01/2019 - 10/2013
2	Atherosclerosis 05/2009 - 10/2002
2	Hypoxia (Hypoxemia) 11/2007 - 05/2006
1	Hyperglycemia 11/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Multiple Sclerosis 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Starvation 01/2023
1	Rheumatoid Arthritis 01/2023
1	Heart Failure 11/2022
1	Monoclonal Gammopathy of Undetermined Significance 11/2022
1	Paraproteinemias (Monoclonal Gammopathy) 11/2022

Drug/Important Bio-Agent (IBA)

15	Neutralizing AntibodiesIBA 11/2023 - 01/2021
15	BNT162 VaccineIBA 03/2023 - 01/2021
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2002
13	VaccinesIBA 01/2023 - 09/2013
13	ClusterinIBA 01/2022 - 10/2002
10	Messenger RNA (mRNA)IBA 01/2023 - 03/2004
9	AntibodiesIBA 11/2023 - 07/2021
8	mRNA VaccinesIBA 03/2023 - 01/2021
8	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 10/2008
7	Proteasome InhibitorsIBA 02/2023 - 12/2017
6	carfilzomibIBA 01/2023 - 12/2017
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2002
4	Metformin (Glucophage)FDA LinkGeneric 11/2023 - 01/2019
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2022 - 01/2018
4	AntioxidantsIBA 01/2019 - 01/2017
4	Glycoproteins (Glycoprotein)IBA 05/2009 - 03/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 06/2004
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2018
3	ProteomeIBA 11/2022 - 01/2018
3	Phosphotransferases (Kinase)IBA 09/2022 - 01/2017
3	CaspasesIBA 08/2022 - 12/2017
3	ChAdOx1 nCoV-19IBA 11/2021 - 01/2021
3	Bortezomib (Velcade)FDA Link 01/2019 - 12/2017
2	N,N'- bis((2- chloroethyl)nitrosocarbamoyl)cystamine (CNCC)IBA 11/2023 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2023 - 10/2019
2	Small Heat-Shock ProteinsIBA 01/2023 - 01/2013
2	ChemokinesIBA 01/2023 - 10/2021
2	CytokinesIBA 01/2023 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2022 - 10/2021
2	Androgen Receptors (Androgen Receptor)IBA 09/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 06/2022 - 12/2019
2	Peptides (Polypeptides)IBA 01/2022 - 09/2013
2	Nerve Growth Factor (NGF)IBA 03/2021 - 12/2019
2	Monoclonal AntibodiesIBA 01/2021 - 12/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2019
2	MicroRNAs (MicroRNA)IBA 09/2020 - 01/2016
2	Protein Isoforms (Isoforms)IBA 10/2019 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 10/2019 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 09/2013
2	Cytotoxins (Cytolysins)IBA 01/2018 - 11/2007
2	Small Interfering RNA (siRNA)IBA 01/2009 - 03/2004
2	Oxygen (Dioxygen)IBA 11/2007 - 05/2006
1	Transcription Factors (Transcription Factor)IBA 03/2024
1	MethyltransferasesIBA 03/2023
1	Cre recombinaseIBA 03/2023
1	Lapatinib (GW572016)FDA Link 03/2023
1	Phenobarbital (Luminal)FDA Link 03/2023
1	SYBR Green IIBA 01/2023
1	2',7'-dichlorodihydrofluorescein diacetateIBA 01/2023
1	Immunoglobulin M (IgM)IBA 11/2022
1	Cell-Free Nucleic AcidsIBA 11/2022
1	Sirolimus (Rapamycin)FDA Link 11/2022
1	Cyclin DIBA 09/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 08/2022
1	Melanins (Melanin)IBA 08/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 08/2022

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2009
4	Immunotherapy 01/2023 - 09/2013
3	Drug Therapy (Chemotherapy) 01/2023 - 02/2007
1	Aftercare (After-Treatment) 01/2023
1	Caloric Restriction 01/2023
1	Chelation Therapy (Therapy, Chelation) 01/2022